TREATMENT OF RENAL OSTEODYSTROPHY IN CHILDREN WITH 1,25 (OH)2 D3

被引：0
|
作者：
MALEKZADEH, MH
PENNISI, AJ
UITTENBOGAART, CH
ETTENGER, RB
FINE, RN
机构：
[1] UNIV SO CALIF,DEPT PEDIAT,LOS ANGELES,CA 90007
[2] CHILDRENS HOSP,DIV DIALYSIS & TRANSPLANTAT,LOS ANGELES,CA 90027
来源：
CLINICAL RESEARCH | 1980年 / 28卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
引用
收藏
页码：A132 / A132
页数：1
相关论文
共 50 条
  • [31] PHOSPHOLIPID MODULATION OF THE 1,25-DIHYDROXY VITAMIN-D3 (1,25 (OH)2 D3) RECEPTOR
    CHEN, TC
    MANUEL, HC
    MULLEN, JP
    PUSCHETT, JB
    CLINICAL RESEARCH, 1984, 32 (02): : A391 - A391
  • [32] 1,25(OH)2D3 AND RENAL-FUNCTION
    JENSEN, GF
    CHRISTIANSEN, C
    TRANSBOL, I
    ACTA MEDICA SCANDINAVICA, 1982, 211 (1-2): : 51 - 54
  • [33] THERAPEUTIC APPROACH TO 1,25-DIHYDROXYVITAMIN D3 [1,25(OH)2D3)]-RESISTANT RICKETS
    HOCHBERG, Z
    JAFFE, M
    BENDERLY, A
    WEISMAN, Y
    PEDIATRIC RESEARCH, 1986, 20 (11) : 1207 - 1207
  • [34] Genetic regulation of 25(OH)D3 and 1,25(OH)2D3 serum concentrations in type 1 diabetes patients
    Badenhoop, K.
    Kahles, H.
    Greissl, C.
    Penna-Martinez, M.
    Shoghi, F.
    Ramos-Lopez, E.
    DIABETOLOGIA, 2010, 53 : S122 - S122
  • [35] A Role for 1,25(OH)2 Vitamin D3 in Ocular Immune Privilege?
    Alsalem, J.
    Susarla, R.
    Ahasan, M. M.
    Coca-Prados, M.
    Bland, R.
    Walker, E. A.
    Rauz, S.
    Wallace, G. R.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2010, 51 (13)
  • [36] 1, 25-Dihydroxycholecalciferol (1,25-(OH)2 D3) levels in osteoporosis
    Narang A.P.S.
    Batra S.
    Sabharwal S.
    Ahuja S.C.
    Indian Journal of Clinical Biochemistry, 2004, 19 (2) : 111 - 113
  • [37] 1,25(OH)2 D3 is an important regulator in organogenesis of bone.
    Hasegawa, K
    Seino, Y
    Kato, S
    Tanaka, H
    JOURNAL OF BONE AND MINERAL RESEARCH, 2004, 19 : S481 - S481
  • [38] 1,25-DIHYDROXYVITAMIN D3 (1,25(OH)2D3) IN INFRARADIOLOGIC DIALYSIS OSTEODYSTROPHY - CURE OF OSTEOMALACIA AND VARIABLE RESPONSE OF RESORPTION DEPENDING ON PLASMA PHOSPHATE VARIATION
    MORINIERE, P
    COEVOET, B
    DEFREMONT, F
    MAKDASSI, R
    KASSOUF, J
    BATAILLE, JP
    LAMBREY, G
    MEUNIER, P
    KUNTZ, D
    FOURNIER, A
    KIDNEY INTERNATIONAL, 1981, 20 (02) : 309 - 310
  • [39] ENDOGENOUS SYNTHESIS OF 24,25(OH)2D3 (24,25D) IS NOT EFFECTIVE ON HEMODIALYSIS OSTEODYSTROPHY (HO) DURING TREATMENT WITH 25OHD3 (25D) AND 1,25(OH)2D3 (1,25D)
    COEN, G
    GALLUCCI, MT
    BONUCCI, E
    BALLANTI, P
    BIANCHINI, G
    MAZZAFERRO, S
    PALMIOTTI, D
    CASCIANI, CU
    CINOTTI, GA
    KIDNEY INTERNATIONAL, 1983, 24 (01) : 128 - 128
  • [40] BONE-MINERAL CONTENT IN PATIENTS WITH CHRONIC-RENAL-FAILURE EFFECTS OF HEMODIALYSIS AND 1,25 DIHYDROXYVITAMIN D3 (1,25(OH)2D3)
    KLEINMAN, KS
    CLINICAL RESEARCH, 1980, 28 (01): : A50 - A50
12345